Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study.
Eur J Clin Pharmacol
; 79(5): 643-655, 2023 May.
Article
en En
| MEDLINE
| ID: mdl-36961578
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Fluvoxamina
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Eur J Clin Pharmacol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Croacia